Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algori...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2018-10, Vol.24 (19), p.4726-4733 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4733 |
---|---|
container_issue | 19 |
container_start_page | 4726 |
container_title | Clinical cancer research |
container_volume | 24 |
creator | Blyuss, Oleg Burnell, Matthew Ryan, Andy Gentry-Maharaj, Aleksandra Mariño, Inés P Kalsi, Jatinderpal Manchanda, Ranjit Timms, John F Parmar, Mahesh Skates, Steven J Jacobs, Ian Zaikin, Alexey Menon, Usha |
description | In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset.
50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared.
The area under receiver operator curve (AUC) was significantly higher (
= 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8).
These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies.
. |
doi_str_mv | 10.1158/1078-0432.CCR-18-0208 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2084914357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</originalsourceid><addsrcrecordid>eNpVkVtr3DAQhUVpaNJNfkKLHvviVKOr_VJYTJMWFhJ6eRZa7XhXxZa2kh3ov6-WXGhBoAOa881Bh5B3wK4BVPsRmGkbJgW_7vtvDVTNWfuKXIBSphFcq9dVP8-ck7el_GIMJDD5hpwLxlrZCnFBUp-mo8uhpEjTQDcp7sO87EJ0I-3XwBVdj_uUw3yYCnX10JuQy9xsQkT63WfESIeU6d1DhbhIexc9ZhoinQ9IbzFirqT7dFxGN4cUL8nZ4MaCV0_3ivy8-fyj_9Js7m6_9utN4yXA3HQtgtaoO8O58ii08Z1DVFw56Y1HZQTvlGRb9B3bGa2Y9lvDsR12bEDtxIp8euQel-2EO49xrkHsMYfJ5T82uWD_f4nhYPfpwWowYKSqgA9PgJx-L1hmO4XicRxdxLQUW39bdiBFTbIi6nHU51RKxuFlDTB7KsueirCnImwty0LV1V597__N-OJ6bkf8BZdfkRs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2084914357</pqid></control><display><type>article</type><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</creator><creatorcontrib>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</creatorcontrib><description>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset.
50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared.
The area under receiver operator curve (AUC) was significantly higher (
= 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8).
These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies.
.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-18-0208</identifier><identifier>PMID: 30084833</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Algorithms ; Biomarkers, Tumor - blood ; CA-125 Antigen - blood ; Early Detection of Cancer ; Female ; Humans ; Longitudinal Studies ; Membrane Proteins - blood ; Middle Aged ; Ovarian Neoplasms - blood ; Ovarian Neoplasms - epidemiology ; Ovarian Neoplasms - pathology ; Risk Factors ; Ultrasonography ; United Kingdom</subject><ispartof>Clinical cancer research, 2018-10, Vol.24 (19), p.4726-4733</ispartof><rights>2018 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</citedby><cites>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</cites><orcidid>0000-0003-3381-5057 ; 0000-0002-0194-6389 ; 0000-0003-0166-1700 ; 0000-0003-3708-1732</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30084833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blyuss, Oleg</creatorcontrib><creatorcontrib>Burnell, Matthew</creatorcontrib><creatorcontrib>Ryan, Andy</creatorcontrib><creatorcontrib>Gentry-Maharaj, Aleksandra</creatorcontrib><creatorcontrib>Mariño, Inés P</creatorcontrib><creatorcontrib>Kalsi, Jatinderpal</creatorcontrib><creatorcontrib>Manchanda, Ranjit</creatorcontrib><creatorcontrib>Timms, John F</creatorcontrib><creatorcontrib>Parmar, Mahesh</creatorcontrib><creatorcontrib>Skates, Steven J</creatorcontrib><creatorcontrib>Jacobs, Ian</creatorcontrib><creatorcontrib>Zaikin, Alexey</creatorcontrib><creatorcontrib>Menon, Usha</creatorcontrib><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset.
50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared.
The area under receiver operator curve (AUC) was significantly higher (
= 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8).
These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies.
.</description><subject>Aged</subject><subject>Algorithms</subject><subject>Biomarkers, Tumor - blood</subject><subject>CA-125 Antigen - blood</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Membrane Proteins - blood</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - blood</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Risk Factors</subject><subject>Ultrasonography</subject><subject>United Kingdom</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVtr3DAQhUVpaNJNfkKLHvviVKOr_VJYTJMWFhJ6eRZa7XhXxZa2kh3ov6-WXGhBoAOa881Bh5B3wK4BVPsRmGkbJgW_7vtvDVTNWfuKXIBSphFcq9dVP8-ck7el_GIMJDD5hpwLxlrZCnFBUp-mo8uhpEjTQDcp7sO87EJ0I-3XwBVdj_uUw3yYCnX10JuQy9xsQkT63WfESIeU6d1DhbhIexc9ZhoinQ9IbzFirqT7dFxGN4cUL8nZ4MaCV0_3ivy8-fyj_9Js7m6_9utN4yXA3HQtgtaoO8O58ii08Z1DVFw56Y1HZQTvlGRb9B3bGa2Y9lvDsR12bEDtxIp8euQel-2EO49xrkHsMYfJ5T82uWD_f4nhYPfpwWowYKSqgA9PgJx-L1hmO4XicRxdxLQUW39bdiBFTbIi6nHU51RKxuFlDTB7KsueirCnImwty0LV1V597__N-OJ6bkf8BZdfkRs</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Blyuss, Oleg</creator><creator>Burnell, Matthew</creator><creator>Ryan, Andy</creator><creator>Gentry-Maharaj, Aleksandra</creator><creator>Mariño, Inés P</creator><creator>Kalsi, Jatinderpal</creator><creator>Manchanda, Ranjit</creator><creator>Timms, John F</creator><creator>Parmar, Mahesh</creator><creator>Skates, Steven J</creator><creator>Jacobs, Ian</creator><creator>Zaikin, Alexey</creator><creator>Menon, Usha</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3381-5057</orcidid><orcidid>https://orcid.org/0000-0002-0194-6389</orcidid><orcidid>https://orcid.org/0000-0003-0166-1700</orcidid><orcidid>https://orcid.org/0000-0003-3708-1732</orcidid></search><sort><creationdate>20181001</creationdate><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><author>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Algorithms</topic><topic>Biomarkers, Tumor - blood</topic><topic>CA-125 Antigen - blood</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Membrane Proteins - blood</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - blood</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Risk Factors</topic><topic>Ultrasonography</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blyuss, Oleg</creatorcontrib><creatorcontrib>Burnell, Matthew</creatorcontrib><creatorcontrib>Ryan, Andy</creatorcontrib><creatorcontrib>Gentry-Maharaj, Aleksandra</creatorcontrib><creatorcontrib>Mariño, Inés P</creatorcontrib><creatorcontrib>Kalsi, Jatinderpal</creatorcontrib><creatorcontrib>Manchanda, Ranjit</creatorcontrib><creatorcontrib>Timms, John F</creatorcontrib><creatorcontrib>Parmar, Mahesh</creatorcontrib><creatorcontrib>Skates, Steven J</creatorcontrib><creatorcontrib>Jacobs, Ian</creatorcontrib><creatorcontrib>Zaikin, Alexey</creatorcontrib><creatorcontrib>Menon, Usha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blyuss, Oleg</au><au>Burnell, Matthew</au><au>Ryan, Andy</au><au>Gentry-Maharaj, Aleksandra</au><au>Mariño, Inés P</au><au>Kalsi, Jatinderpal</au><au>Manchanda, Ranjit</au><au>Timms, John F</au><au>Parmar, Mahesh</au><au>Skates, Steven J</au><au>Jacobs, Ian</au><au>Zaikin, Alexey</au><au>Menon, Usha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>24</volume><issue>19</issue><spage>4726</spage><epage>4733</epage><pages>4726-4733</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset.
50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared.
The area under receiver operator curve (AUC) was significantly higher (
= 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8).
These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies.
.</abstract><cop>United States</cop><pmid>30084833</pmid><doi>10.1158/1078-0432.CCR-18-0208</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3381-5057</orcidid><orcidid>https://orcid.org/0000-0002-0194-6389</orcidid><orcidid>https://orcid.org/0000-0003-0166-1700</orcidid><orcidid>https://orcid.org/0000-0003-3708-1732</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2018-10, Vol.24 (19), p.4726-4733 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171745 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Aged Algorithms Biomarkers, Tumor - blood CA-125 Antigen - blood Early Detection of Cancer Female Humans Longitudinal Studies Membrane Proteins - blood Middle Aged Ovarian Neoplasms - blood Ovarian Neoplasms - epidemiology Ovarian Neoplasms - pathology Risk Factors Ultrasonography United Kingdom |
title | Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A59%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Longitudinal%20CA125%20Algorithms%20as%20a%20First-Line%20Screen%20for%20Ovarian%20Cancer%20in%20the%20General%20Population&rft.jtitle=Clinical%20cancer%20research&rft.au=Blyuss,%20Oleg&rft.date=2018-10-01&rft.volume=24&rft.issue=19&rft.spage=4726&rft.epage=4733&rft.pages=4726-4733&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-18-0208&rft_dat=%3Cproquest_pubme%3E2084914357%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2084914357&rft_id=info:pmid/30084833&rfr_iscdi=true |